This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Noda-Heiny, H. Articles by Sobel, B. E. Search for Related Content PubMed PubMed Citation Articles by Noda-Heiny, H. Articles by Sobel, B. E.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:37-43.)
© 1995 American Heart Association, Inc.

Articles

Augmented Urokinase Receptor Expression in Atheroma

Hiroko Noda-Heiny; Alan Daugherty; Burton E. Sobel

From the Cardiovascular Division and the Department of Biochemistry and Molecular Biophysics (A.D.), Washington University School of Medicine, St Louis, Mo.

Correspondence to Hiroko Noda-Heiny, MD, Cardiovascular Division, Box 8086, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110.

Abstract Smooth muscle cell proliferation and migration into neointima are hallmarks of atherogenesis. However, mechanisms responsible have not yet been fully elucidated. One potential mediator of both smooth muscle cell proliferation and migration is activation of plasminogen by activators bound to receptors on cells within the vessel wall. To determine whether vascular smooth muscle cells within atheroma express the receptor for urokinase-type plasminogen activator (uPA-R), we characterized atheroma in cholesterol-fed New Zealand White rabbits and human subjects by immunostaining. Intense immunostaining of uPA-R was observed throughout the neointima in both rabbit and human atherosclerotic lesions with the use of a monoclonal antibody to uPA-R. uPA-R was not detectable in normal arterial tissues. uPA-R was localized to macrophages and neointimal smooth muscle cells identified by immunostaining in serial sections. Furthermore, uPA-R protein in extracts from atheroma was present in at least a ninefold greater quantity compared with extracts from normal vessels, as shown by Western blotting. Expression of uPA-R mRNA in migrating vascular smooth muscle cells did not increase significantly. Thus, altered posttranscriptional regulation may be contributing to the increased uPA-R. In vitro, antibodies to uPA-R delayed the migration of cultured vascular smooth muscle cells. Our results suggest that increased cell-surface uPA-R contributes to pericellular proteolysis and consequently increased neointimalization secondary to increased vascular smooth muscle cell migration in atheroma.

Key Words: atherogenesis • restenosis • cell migration • plasminogen activators

This article has been cited by other articles:

				H. Bujo and Y. Saito Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1246 - 1252. [Abstract] [Full Text] [PDF]

				H. Hao, G. Gabbiani, and M.-L. Bochaton-Piallat Arterial Smooth Muscle Cell Heterogeneity: Implications for Atherosclerosis and Restenosis Development Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1510 - 1520. [Abstract] [Full Text] [PDF]

				A. HAJ-YEHIA, T. NASSAR, B. S. SACHAIS, A. KUO, K. BDEIR, A. B. AL-MEHDI, A. MAZAR, D. B. CINES, and A. A.-R. HIGAZI Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo FASEB J, July 1, 2000; 14(10): 1411 - 1422. [Abstract] [Full Text]

				F. Werner, T. M. Razzaq, and V. Ellis Tissue Plasminogen Activator Binds to Human Vascular Smooth Muscle Cells by a Novel Mechanism. EVIDENCE FOR A RECIPROCAL LINKAGE BETWEEN INHIBITION OF CATALYTIC ACTIVITY AND CELLULAR BINDING J. Biol. Chem., July 30, 1999; 274(31): 21555 - 21561. [Abstract] [Full Text] [PDF]

				A. W. Chang, A. Kuo, E. S. Barnathan, and S. S. Okada Urokinase Receptor-Dependent Upregulation of Smooth Muscle Cell Adhesion to Vitronectin by Urokinase Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1855 - 1860. [Abstract] [Full Text] [PDF]

				A. A.-R. Higazi, K. Bdeir, E. Hiss, S. Arad, A. Kuo, I. Barghouti, and D. B. Cines Lysis of Plasma Clots by Urokinase-Soluble Urokinase Receptor Complexes Blood, September 15, 1998; 92(6): 2075 - 2083. [Abstract] [Full Text] [PDF]

				M.-L. Bochaton-Piallat, G. Gabbiani, and M. S. Pepper Plasminogen Activator Expression in Rat Arterial Smooth Muscle Cells Depends on Their Phenotype and Is Modulated by Cytokines Circ. Res., June 1, 1998; 82(10): 1086 - 1093. [Abstract] [Full Text] [PDF]

				P. H. A. Quax, J. M. Grimbergen, M. Lansink, A. H. F. Bakker, M.-C. Blatter, D. Belin, V. W. M. van Hinsbergh, and J. H. Verheijen Binding of Human Urokinase-Type Plasminogen Activator to Its Receptor : Residues Involved in Species Specificity and Binding Arterioscler Thromb Vasc Biol, May 1, 1998; 18(5): 693 - 701. [Abstract] [Full Text] [PDF]

				S. M. Kanse, O. Benzakour, C. Kanthou, C. Kost, H. R. Lijnen, and K. T. Preissner Induction of Vascular SMC Proliferation by Urokinase Indicates a Novel Mechanism of Action in Vasoproliferative Disorders Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2848 - 2854. [Abstract] [Full Text]

				R. T. Lee and P. Libby The Unstable Atheroma Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1859 - 1867. [Full Text]

				J.-M. Herbert, I. Lamarche, and P. Carmeliet Urokinase and Tissue-type Plasminogen Activator Are Required for the Mitogenic and Chemotactic Effects of Bovine Fibroblast Growth Factor and Platelet-derived Growth Factor-BB for Vascular Smooth Muscle Cells J. Biol. Chem., September 19, 1997; 272(38): 23585 - 23591. [Abstract] [Full Text] [PDF]

				S. S. Okada, S. R. Grobmyer, and E. S. Barnathan Contrasting Effects of Plasminogen Activators, Urokinase Receptor, and LDL Receptor–Related Protein on Smooth Muscle Cell Migration and Invasion Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1269 - 1276. [Abstract] [Full Text]

				M. A. Reidy, C. Irvin, and V. Lindner Migration of Arterial Wall Cells : Expression of Plasminogen Activators and Inhibitors in Injured Rat Arteries Circ. Res., March 1, 1996; 78(3): 405 - 414. [Abstract] [Full Text]

				E. Lee, D. E. Vaughan, S. H. Parikh, A. J. Grodzinsky, P. Libby, M. W. Lark, and R. T. Lee Regulation of Matrix Metalloproteinases and Plasminogen Activator Inhibitor-1 Synthesis by Plasminogen in Cultured Human Vascular Smooth Muscle Cells Circ. Res., January 1, 1996; 78(1): 44 - 49. [Abstract] [Full Text]

				P.N. Raghunath, J. E. Tomaszewski, S. T. Brady, R. J. Caron, S. S. Okada, and E. S. Barnathan Plasminogen Activator System in Human Coronary Atherosclerosis Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1432 - 1443. [Abstract] [Full Text]

				D. Shiffman, T. Mikita, J. T. N. Tai, D. P. Wade, J. G. Porter, J. J. Seilhamer, R. Somogyi, S. Liang, and R. M. Lawn Large Scale Gene Expression Analysis of Cholesterol-loaded Macrophages J. Biol. Chem., November 22, 2000; 275(48): 37324 - 37332. [Abstract] [Full Text] [PDF]